Paper
Organic & Biomolecular Chemistry
group was demonstrated to be detrimental during BBr3
mediated demethylations, and (viii) in the formation of
chroman-fused 2-arylbenzofurans (23 and 27), a domino
sequence involving elimination/cross-coupling/deprotection/
cyclization was proposed as a probable pathway.
S.-Q. Wang and X.-N. Wang, Chin. Chem. Lett., 2017, 28, 37–
40; (l) Z. Yang, Y. Wang, Y. Wang and Y. Zhang, Food
Chem., 2012, 131, 617–625; (m) Z. Wang, Y. Wang, B. Wang,
W. Li, L. Huang and X. Li, J. Med. Chem., 2015, 58, 8616–
8637; (n) K. C. Nicolaou, J. A. Pfefferkorn and G.-Q. Cao,
Angew. Chem., Int. Ed., 2000, 39, 734–739.
2 (a) G. D. M. Kapche, P. Waffo-Teguo, S. Massip, J. Guillon,
C. Vitrac, S. Krisa, B. Ngadjui and J.-M. Merillon, Anal. Sci.:
X-Ray Struct. Anal. Online, 2007, 23, 59–60; (b) M. Takasugi,
S. Nagao, S. Ueno, T. Masamune, A. Shirata and
K. Takahashi, Chem. Lett., 1978, 7, 1239–1240;
(c) M. Takasugi, S. Nagao and T. Masamune, Tetrahedron
Lett., 1979, 20, 4675–7678; (d) P. C. Stevenson and
N. C. Veitch, Phytochemistry, 1998, 48, 947–951;
(e) Q.-F. Hu, B. Zhou, J.-M. Huang, X.-M. Gao, L.-D. Shu,
G.-Y. Yang and C.-T. Che, J. Nat. Prod., 2013, 76, 292–296;
(f) L. Wang, X.-Q. Cui, T. Gong, R.-Y. Yan, Y.-X. Tan and
R.-Y. Chen, J. Asian Nat. Prod. Res., 2008, 10, 897–902.
3 (a) Z. Novák, G. Timári and A. Kotschy, Tetrahedron, 2003,
59, 7509–7513; (b) S. N. Aslam, P. C. Stevenson,
S. J. Phythian, N. C. Veitch and D. R. Hall, Tetrahedron,
2006, 62, 4212–4226; (c) X.-F. Duan, J. Zeng, Z.-B. Zhang
and G.-F. Zi, J. Org. Chem., 2007, 72, 10283–10286;
(d) Y. Jiang, B. Gao, W. Huang, Y. Liang, G. Huang and
Y. Ma, Synth. Commun., 2009, 39, 197–204; (e) K. Damodar,
J.-K. Kim and J.-G. Jun, Tetrahedron Lett., 2016, 57, 1183–
1186; (f) L.-Y. Liao, G. Shen, X. Zhang and X.-F. Duan,
Green Chem., 2012, 14, 695–701; (g) J. J. Lee, S.-R. Yun and
J.-G. Jun, Bull. Korean Chem. Soc., 2014, 35, 3453–3458;
(h) L. Arias, Y. Vara and F. P. Cossío, J. Org. Chem., 2012, 77,
266–275; (i) T. Xu, E. Zhang, D. Wang, Y. Wang and Y. Zou,
J. Org. Chem., 2015, 80, 4313–4324; ( j) D. Wu, H. Mei,
P. Tan, W. Lu, J. Zhu, W. Wang, J. Huang and J. Li,
Tetrahedron Lett., 2015, 56, 4383–4387; (k) J. M. Clough,
I. S. Mann and D. A. Widdowson, Tetrahedron Lett., 1987,
28, 2645–2648; (l) I. S. Mann and D. A. Widdowson,
Tetrahedron, 1991, 47, 7981–7990; (m) M. Watanabe,
K. Kawanishi and S. Furukawa, Chem. Pharm. Bull., 1991,
39, 579–583; (n) T. Kinoshita and K. Ichinose, Heterocycles,
2005, 65, 1641–1654; (o) D.-D. Qin, W. Chen, X. Tang,
W. Yu, A.-A. Wu, Y. Liao and H.-B. Chen, Asian J. Org.
Chem., 2016, 1345–1352; (p) R. M. Walunj, A. D. Natu,
M. V. Paradkar and S. R. Rojatkar, Synth. Commun., 2016,
46, 1425–1431; (q) G. D. McAllister, R. C. Hartley,
M. J. Dawson and A. R. Knaggs, J. Chem. Soc., Perkin Trans.
1, 1998, 3453–3457.
Conclusions
The application of the protecting group manoeuvring as a syn-
thetic strategy was demonstrated in conjunction with the
domino coupling process in the synthesis of benzofuran-based
natural products (1–8). The electronic demands of functional
groups and their tuning to derive the desired reactivity were
successfully managed by employing acetyl protected 4-(2,2-
dibromovinyl)benzene-1,3-diol (12a) and 6-(2,2-dibromovinyl)-
2,2-dimethylchroman-7-ol (22) in domino couplings with triar-
ylbismuth reagents. This approach in short paved the way for
the total synthesis of moracin D (3) and moracin E (4) for the
first time along with natural products (1, 2 and 5–8) in good
yields.
Conflicts of interest
There are no conflicts to declare.
Acknowledgements
We acknowledge the financial support from the Council of
Scientific and Industrial Research (CSIR), New Delhi [02(0091)/
12/EMR-II]. V. N. M. and S. N. acknowledge the research fellow-
ship support of CSIR, New Delhi.
Notes and references
1 (a) A. Radadiya and A. Shah, Eur. J. Med. Chem., 2015, 97,
356–357;
(b) H.
Khanam
and Shamsuzzaman,
Eur. J. Med. Chem., 2015, 97, 483–504; (c) R. Naik,
D. S. Harmalkar, X. Xu, K. Jang and K. Lee, Eur. J. Med.
Chem., 2015, 90, 379–393; (d) Z.-G. Yang, K. Matsuzaki,
S. Takamatsu and S. Kitanaka, Molecules, 2011, 16, 6010–
6022; (e) J.-W. Jung, W.-M. Ko, J.-H. Park, K.-H. Seo,
E.-J. Oh, D.-Y. Lee, D.-S. Lee, Y.-C. Kim, D.-W. Lim, D. Han
and N.-I. Baek, Arch. Pharmacal Res., 2015, 38, 2066–2075;
(f) S.-K. Chen, P. Zhao, Y.-X. Shao, Z. Li, C. Zhang, P. Liu,
X. He, H.-B. Luo and X. Hu, Bioorg. Med. Chem. Lett., 2012,
22, 3261–3264; (g) Y.-X. Tan, Y. Yang, T. Zhang, R.-Y. Chen
and D.-Q. Yu, Fitoterapia, 2010, 81, 742–746; (h) X. Hu,
J.-W. Wu, M. Wang, M.-H. Yu, Q.-S. Zhao, H.-Y. Wang and
A.-J. Hou, J. Nat. Prod., 2012, 75, 82–87; (i) S. N. Aslam,
P. C. Stevenson, T. Kokubun and D. R. Hall, Microbiol. Res.,
2009, 164, 191–195; ( j) G. T. M. Getti, S. N. Aslam,
D. P. Humber, P. C. Stevenson and R. A. Cheke, Planta
Med., 2006, 72, 907–911; (k) X.-L. Wang, X.-X. Di, T. Shen,
4 (a) M. L. N. Rao and V. N. Murty, Eur. J. Org. Chem., 2016,
2177–2186; (b) M. L. N. Rao, D. N. Jadhav and P. Dasgupta,
Eur. J. Org. Chem., 2013, 781–788; (c) K. Urgin, C. Aubé,
C. Pichon, M. Pipelier, V. Blot, C. Thobie-Gautier,
E. Léonel, D. Dubreuil and S. Condon, Tetrahedron Lett.,
2012, 53, 1894–1896.
5 S. Shimada and M. L. N. Rao, Top. Curr. Chem., 2011, 311,
199–228.
6 (a) S. Ramadas and G. L. D. Krupadanam, Tetrahedron:
Asymmetry, 2000, 11, 3375–3393; (b) N. B. Desai, N. Mckelvie
Org. Biomol. Chem.
This journal is © The Royal Society of Chemistry 2017